nsp12 viral polymerase inhibitor (Arbutus Biopharma)

N/A

Report date: 2025/04/14 16:50:47

Base Information

Drug Namensp12 viral polymerase inhibitor (Arbutus Biopharma)
Drug Alias NameSARS-CoV-2 Nsp12 inhibitor (Arbutus Biopharma)
ClassificationBiologics
Mechanisms of ActionCoronavirus spike glycoprotein inhibitors
TargetsCoronavirus spike glycoprotein
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesArbutus Biopharma Corp
China Registration ClassN/A

Develop Information

Active CompaniesArbutus Biopharma Corp
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A